HCN1 channel subunits are a molecular substrate for hypnotic actions of ketamine

J Neurosci. 2009 Jan 21;29(3):600-9. doi: 10.1523/JNEUROSCI.3481-08.2009.

Abstract

Ketamine has important anesthetic, analgesic, and psychotropic actions. It is widely believed that NMDA receptor inhibition accounts for ketamine actions, but there remains a dearth of behavioral evidence to support this hypothesis. Here, we present an alternative, behaviorally relevant molecular substrate for anesthetic effects of ketamine: the HCN1 pacemaker channels that underlie a neuronal hyperpolarization-activated cationic current (I(h)). Ketamine caused subunit-specific inhibition of recombinant HCN1-containing channels and neuronal I(h) at clinically relevant concentrations; the channels were more potently inhibited by S-(+)-ketamine than racemic ketamine, consistent with anesthetic actions of the compounds. In cortical pyramidal neurons from wild-type, but not HCN1 knock-out mice, ketamine induced membrane hyperpolarization and enhanced dendritosomatic synaptic coupling; both effects are known to promote cortical synchronization and support slow cortical rhythms, like those accompanying anesthetic-induced hypnosis. Accordingly, we found that the potency for ketamine to provoke a loss-of-righting reflex, a behavioral correlate of hypnosis, was strongly reduced in HCN1 knock-out mice. In addition, hypnotic sensitivity to two other intravenous anesthetics in HCN1 knock-out mice matched effects on HCN1 channels; propofol selectively inhibited HCN1 channels and propofol sensitivity was diminished in HCN1 knock-out mice, whereas etomidate had no effect on HCN1 channels and hypnotic sensitivity to etomidate was unaffected by HCN1 gene deletion. These data advance HCN1 channels as a novel molecular target for ketamine, provide a plausible neuronal mechanism for enhanced cortical synchronization during anesthetic-induced hypnosis and suggest that HCN1 channels might contribute to other unexplained actions of ketamine.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Animals, Newborn
  • Biophysical Phenomena
  • Cell Line, Transformed
  • Cerebral Cortex / cytology
  • Cyclic Nucleotide-Gated Cation Channels / antagonists & inhibitors
  • Cyclic Nucleotide-Gated Cation Channels / deficiency
  • Cyclic Nucleotide-Gated Cation Channels / genetics
  • Cyclic Nucleotide-Gated Cation Channels / metabolism*
  • Electric Stimulation / methods
  • Etomidate / pharmacology
  • Excitatory Postsynaptic Potentials / drug effects
  • Excitatory Postsynaptic Potentials / genetics
  • Female
  • Green Fluorescent Proteins / genetics
  • Humans
  • Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
  • Hypnotics and Sedatives / pharmacology*
  • In Vitro Techniques
  • Ketamine / pharmacology*
  • Male
  • Membrane Potentials / drug effects
  • Membrane Potentials / genetics
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Neural Inhibition / drug effects
  • Neural Inhibition / genetics
  • Neurons / drug effects*
  • Patch-Clamp Techniques
  • Potassium Channels / deficiency
  • Potassium Channels / genetics
  • Potassium Channels / metabolism*
  • Protein Subunits / genetics
  • Protein Subunits / metabolism*
  • Pyrimidines / pharmacology
  • Transfection

Substances

  • Cyclic Nucleotide-Gated Cation Channels
  • HCN1 protein, human
  • Hcn1 protein, mouse
  • Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
  • Hypnotics and Sedatives
  • Potassium Channels
  • Protein Subunits
  • Pyrimidines
  • ICI D2788
  • Green Fluorescent Proteins
  • Ketamine
  • Etomidate